entertainment -WSS

entertainment

author：knowledge 2025-09-03 11:51:45 - browse：7

It’s no secret that biotech industry funding has fallen from its Covid highs. But with just a few months left in the year, it’s on track to hit lows that predate the pandemic.

New data from Pitchbook and the National Venture Capital Association show that both the number of deals and the amount of money that’s being invested in life science companies are down significantly. So far this year, there have been 1,384 VC deals struck in the field, the lowest figure since 2013. For comparison, there were roughly 2,122 financing deals made last year.

If dealmaking remains consistent for the rest of the year, it would put this year on par with the number of deals made in 2017.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Drug repurposing or repositioning? The language matters
Next article： Readout Newsletter: Ozempic panic wanes, Legend x Novartis, etc.

WSS

NIH chief: government has fallen behind pharma on clinical trials

Immune cells and nerve overgrowth may explain recurring UTI pain

First over

Ozempic has benefits for kidney disease as well as diabetes

Streamlined flu vaccines recommended by FDA advisory panel

Ozempic has benefits for kidney disease as well as diabetes

knowledge

entertainment

focus

Dobbs anniversary: the lost opportunity of abortion as health care

Medicare drug price negotiation continues, as pharma counteroffers

FDA approval of Sarepta Duchenne genetic therapy gives me hope

A new approach to psychiatric drug development

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Ozempic has benefits for kidney disease as well as diabetes

Heart attack and stroke risk calculators need revising

Readout Newsletter: Zepbound, Valneva's vaccine, and more

United colonoscopy coverage change 'may cost lives,' doctors say

$1 billion proposal to grow Boston, Massachusetts biotech

knowledge

Study suggests Covid rebound is far more common with Paxlovid than without

Weight loss drugs should be covered by insurers, AMA says

Lack of health data on LGBTQ+ people has serious consequences

Eli Lilly’s chief scientist on obesity drugs, gene editing, and more

What health policies could hitch a ride on a spending bill?

Cancer diagnosis changes perspective doctor, former hospital CEO

Wikipedia

Wikipedia

knowledge

explore